CHAMPIONS ONCOLOGY, INC. Revenue Breakdown
No Revenue Breakdown for CSBR on this site yet.
- 2026-04-30: Others Not split by product in the filing$59.42M100.00%; Total revenue $59.42M.
- 2025-04-30: Others Not split by product in the filing$56.94M100.00%; Total revenue $56.94M.
- 2024-04-30: Others Not split by product in the filing$50.16M100.00%; Total revenue $50.16M.
- 2023-04-30: Others Not split by product in the filing$53.87M100.00%; Total revenue $53.87M.
Source checked: the stored Revenue Breakdown page for CSBR.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2026-04-30 | Not split by product in the filing $59.42M 100.00% | $59.42M |
| 2025-04-30 | Not split by product in the filing $56.94M 100.00% | $56.94M |
| 2024-04-30 | Not split by product in the filing $50.16M 100.00% | $50.16M |
| 2023-04-30 | Not split by product in the filing $53.87M 100.00% | $53.87M |
| 2022-04-30 | Not split by product in the filing $49.11M 100.00% | $49.11M |
| 2021-04-30 | Not split by product in the filing $41.04M 100.00% | $41.04M |
| 2020-04-30 | Not split by product in the filing $32.12M 100.00% | $32.12M |
| 2019-04-30 | Not split by product in the filing $27.07M 100.00% | $27.07M |
| 2018-04-30 | Not split by product in the filing $20.24M 100.00% | $20.24M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-07-31 | Not split by product $15.23M 100.00% | $15.23M |
| 2026-04-30 | Not split by product $13.84M 100.00% | $13.84M |
| 2026-01-31 | Not split by product $16.56M 100.00% | $16.56M |
| 2025-10-31 | Not split by product $15.04M 100.00% | $15.04M |
| 2025-07-31 | Not split by product $13.99M 100.00% | $13.99M |
| 2025-04-30 | Not split by product $12.36M 100.00% | $12.36M |
| 2025-01-31 | Not split by product $17.04M 100.00% | $17.04M |
| 2024-10-31 | Not split by product $13.49M 100.00% | $13.49M |
| 2024-07-31 | Not split by product $14.06M 100.00% | $14.06M |
| 2024-04-30 | Not split by product $14.00M 100.00% | $14.00M |
| 2024-01-31 | Not split by product $12.02M 100.00% | $12.02M |
| 2023-10-31 | Not split by product $11.57M 100.00% | $11.57M |
| 2023-07-31 | Not split by product $12.56M 100.00% | $12.56M |
| 2023-04-30 | Not split by product $13.07M 100.00% | $13.07M |
| 2023-01-31 | Not split by product $12.77M 100.00% | $12.77M |
| 2022-10-31 | Not split by product $14.28M 100.00% | $14.28M |
| 2022-07-31 | Not split by product $13.74M 100.00% | $13.74M |
| 2022-04-30 | Not split by product $12.88M 100.00% | $12.88M |
| 2022-01-31 | Not split by product $13.19M 100.00% | $13.19M |
| 2021-10-31 | Not split by product $11.79M 100.00% | $11.79M |
| 2021-07-31 | Not split by product $11.25M 100.00% | $11.25M |
| 2021-04-30 | Not split by product $10.56M 100.00% | $10.56M |
| 2021-01-31 | Not split by product $10.81M 100.00% | $10.81M |
| 2020-10-31 | Not split by product $10.12M 100.00% | $10.12M |
| 2020-07-31 | Not split by product $9.55M 100.00% | $9.55M |
| 2020-04-30 | Not split by product $8.75M 100.00% | $8.75M |
| 2020-01-31 | Not split by product $9.01M 100.00% | $9.01M |
| 2019-10-31 | Not split by product $7.63M 100.00% | $7.63M |
| 2019-07-31 | Not split by product $6.74M 100.00% | $6.74M |
| 2019-04-30 | Not split by product $7.72M 100.00% | $7.72M |
| 2019-01-31 | Not split by product $6.43M 100.00% | $6.43M |
| 2018-07-31 | Not split by product $6.22M 100.00% | $6.22M |
| 2017-07-31 | Not split by product $5.03M 100.00% | $5.03M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |